Dr Jasjit Baveja is the Associate Director of Policy at the Medical Technology Association of Australia (MTAA), where she oversees regulatory affairs, clinical code of practice, procurement, industry policy, reimbursement, and advocacy. With over 20 years of experience in the medical device regulatory space, Dr Bavej’s expertise lies in providing educational opportunities for regulatory professionals in Australia to ensure continuous learning and professional development. She collaborates closely with the Therapeutic Goods Administration (TGA) to run workshops that provide invaluable experience, networking opportunities, and skill enhancement.
Regulations, such as the Therapeutic Goods Act of 1989, the Therapeutic Goods Regulations of 1990, and the Therapeutic Goods Medical Device Regulations of 2002, serve as a cornerstone for the medical technology industry and are essential in ensuring patient safety and promoting innovation within the industry.
According to Dr Baveja, “Setting stringent quality standards throughout the lifecycle of the medical device, regulations safeguard patient and public health by ensuring only safe and effective medical devices are on the market. With the confidence instilled in patients, healthcare workers, and broader stakeholders that any device that has gone through rigorous testing has met the scrutiny of regulatory requirements, the uptake of medical technology and novel medical devices is facilitated.”
MTAA offers workshops in medical device regulatory affairs for regulatory professionals, providing comprehensive education on Australian medical device regulations to enhance patient access to medical devices and streamline regulatory processes for faster approval times.
The Medical Technology Association of Australia (MTAA) is the national association representing companies in the medical technology industry.
MTAA represents manufacturers and suppliers of medical technology used in the diagnosis, prevention, treatment and management of disease and disability. The range of medical technology is diverse with products ranging from familiar items such as syringes and wound dressings, through to high-technology implanted devices such as pacemakers, defibrillators, hip and other orthopaedic implants. Products also include hospital and diagnostic imaging equipment such as ultrasounds and magnetic resonance imaging machines.
-
Global collaboration in pulmonary fibrosis research
Pulmonary fibrosis is a lung disease that occurs when lung tissue becomes damaged and scarred. The debilitating and fatal disease ended the life of an Australian man 8 years ago.
His son led philanthropic efforts to establish the connection between 2 Australian organisations; Lung Foundation Australia and Centre for Research Excellence in Pulmonary Fibrosis and the US based, Three Lakes Foundation. The three organisations recently announced a collaboration to create a global network for PF research.
-
Nursing Now Australia Launches
The evening of Tuesday 9th April saw the launch of Nursing Now Australia in Sydney, with Lord Nigel Crisp, Co-Chair of Nursing Now.
Professor Christine Duffield FACN, President of Australian College of Nursing welcomed the start of the campaign and explained the relevance to Australian Nurses.
-
Clinical pain neuroscientist talks about how the brain processes pain information
Persistent pain affects one in five Australians and costs the nation an estimated $73 billion per year in health system costs, lost productivity and other financial costs.
Persistent pain also has debilitating personal costs – negatively impacting quality of life and the ability to engage in meaningful work and life activities.
Despite the enormity of this problem, very few effective treatments exist with most showing only small to moderate improvements. New treatments are desperately needed. The group believes the best way to create impactful change is to work with people with lived experience of persistent pain to devise solutions with them, not for them.
